Holen Sie sich die Stockscreener-App
282.63
2.48%
6.83
Handel nachbörslich:
282.74
0.11
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$275.80
Offen:
$275.4
24-Stunden-Volumen:
1.67M
Relative Volume:
0.91
Marktkapitalisierung:
$34.03B
Einnahmen:
$115.01B
Nettoeinkommen (Verlust:
$1.36B
KGV:
25.03
EPS:
11.29
Netto-Cashflow:
$-4.34B
1W Leistung:
+5.05%
1M Leistung:
+20.84%
6M Leistung:
-29.72%
1J Leistung:
-36.88%
1-Tages-Spanne:
$270.86
$287.06
1-Wochen-Bereich:
$268.44
$290.67
52-Wochen-Spanne:
$213.31
$415.73
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
282.63 | 34.03B | 115.01B | 1.36B | -4.34B | 11.29 |
|
UNH
Unitedhealth Group Inc
|
509.76 | 469.12B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
385.29 | 89.36B | 174.02B | 6.42B | 871.00M | 27.43 |
|
CI
Cigna Group
|
283.99 | 78.99B | 229.75B | 3.04B | 5.18B | 10.60 |
|
CVS
Cvs Health Corp
|
52.62 | 62.83B | 368.91B | 5.02B | 1.69B | 3.94 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Sanibel Captiva Trust Company Inc. Trims Stake in Humana Inc. (NYSE:HUM) - MarketBeat
Jim Cramer on Humana Inc. (HUM): ‘Medicare Provisions Were Much Better Than Expected On Friday. Should Really Help Humana All Day’ - Insider Monkey
Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires - Insider Monkey
Avanza Fonder AB Acquires Shares of 9,947 Humana Inc. (NYSE:HUM) - MarketBeat
Park Avenue Securities LLC Increases Stake in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc (NYSE:HUM): A Bullish Investment Perspective - MSN
Biogen Beats Humana's RICO Suit Over MS Drug Scheme on Appeal - Bloomberg Law
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why it is Prudent for Investors to Hold Humana Stock for Now - MSN
Humana Leads in Customer Experience in Forrester Health Insurance Report - Managed Healthcare Executive
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On? - Benzinga
What's Going On With Humana Stock?Humana (NYSE:HUM) - Benzinga
Humana (NYSE:HUM) Price Target Raised to $288.00 at Piper Sandler - MarketBeat
Medical membership of Humana in the U.S. 2008-2023 - Statista
Humana Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
A Glimpse Into The Expert Outlook On Humana Through 7 Analysts - Benzinga
Humana Takes Pharmacy Services Tax Row To Minn. Justices - Law360
Should Value Investors Buy Humana (HUM) Stock? - Yahoo Finance
FNY Investment Advisers LLC Has $6.92 Million Position in Humana Inc. (NYSE:HUM) - MarketBeat
Fiduciary Alliance LLC Acquires Shares of 5,418 Humana Inc. (NYSE:HUM) - MarketBeat
Largest Health Insurance Companies - ValuePenguin
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday? - Benzinga
What's Going On With CVS, Humana and UnitedHealth Shares Monday? - Benzinga
Humana (NYSE:HUM) Shares Gap UpStill a Buy? - MarketBeat
Market Whales and Their Recent Bets on HUM Options - Benzinga
Humana, UnitedHealth, CVS Jump On Potential Medicare Advantage Payment Boost - Yahoo Finance
S&P 500 Futures Fall in Premarket Trading; Intra-Cellular Therapies, Zurn Elkay Water Solns Lead - Barron's
Humana stock rises on Medicare payment proposal - Investing.com
Humana stock rises on Medicare payment proposal By Investing.com - Investing.com Canada
Zacks Industry Outlook Highlights UnitedHealth, Humana And Centene - Barchart
Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene - Yahoo Finance
US proposes payment rate for 2026 Medicare Advantage insurers - Reuters
HUMANA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humana Inc.HUM - Business Wire
Humana’s Growth Vs. Rising Costs: Why It’s A Hold For Cautious Investors (NYSE:HUM) - Seeking Alpha
Humana Sets Date for Q4 2024 Earnings Release and 2025 Financial Guidance - StockTitan
Humana Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
First Hawaiian Bank Acquires 4,494 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Vanguard Group Inc's Strategic Acquisition of Humana Inc Shares - GuruFocus.com
Humana Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index - Business Wire
5th Circ. Iffy On Humana, Blue Cross Allergy Meds Denials - Law360
Saint Alphonsus no longer part of Humana Medicare Advantage health care network - Baker City Herald
Behind the Scenes of Humana's Latest Options Trends - Benzinga
Humana, Trinity rift leaves nearly 28,000 senior patients to seek new providers - Crain's Detroit Business
Humana's Quarterly Earnings Preview: What You Need to Know - Nasdaq
Humana (NYSE:HUM) Price Target Raised to $290.00 at Truist Financial - MarketBeat
Humana Inc. (NYSE:HUM) Insider Sells $948,930.78 in Stock - Defense World
GAMMA Investing LLC Purchases 554 Shares of Humana Inc. (NYSE:HUM) - Defense World
Humana's Quarterly Earnings Preview: What You Need To Know - Barchart
Aultman Hospital no longer 'in network' for Humana Medicare Advantage - AOL
Humana Inc. (NYSE:HUM) Receives Average Rating of "Hold" from Analysts - MarketBeat
'Nothing I can do': Woman concerned over healthcare after Humana, Trinity Health cut ties - FOX 17 West Michigan News
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):